Cite
HARVARD Citation
Ilhan-Mutlu, A. et al. (2018). Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysis. Cancer biology & therapy. 19 (3), pp. 169-174. [Online].